Results 131 to 140 of about 17,683 (178)

Macular translocation for neovascular age-related macular degeneration

Cochrane Database of Systematic Reviews, 2008
Macular translocation has been proposed by vitreoretinal surgeons to displace the neuroretinal tissue onto healthy retinal pigment epithelium and choroid when the macula has been invaded by subretinal neovascularisation.This review aims at assessing the effectiveness of macular translocation for preserving or improving vision in patients with ...
Eandi CM, GIANSANTI, FABRIZIO, VIRGILI, GIANNI   +2 more
openaire   +4 more sources

Imaging in Neovascular Age-Related Macular Degeneration

Seminars in Ophthalmology, 2011
Imaging plays an essential role in the diagnosis and treatment of age-related macular degeneration (AMD). This review describes the imaging modalities most commonly employed by ophthalmologists caring for patients with neovascular AMD. Imaging modalities discussed include fluorescein angiography, optical coherence tomography, indocyanine green ...
Adam J, Gess, Anne E, Fung, Jorge G, Rodriguez   +2 more
openaire   +2 more sources

Age-related Macular Degeneration and Choroidal Neovascularization

American Journal of Ophthalmology, 1993
The neovascular variant of age-related macular degeneration is amenable to laser photocoagulation treatment within well-defined guidelines established by clinical trials. However, only a limited number of patients meet eligibility criteria for this form of treatment, principally because of the ill-defined, or occult nature, of the choroidal ...
K B, Freund, L A, Yannuzzi, J A, Sorenson   +2 more
openaire   +2 more sources

Ranibizumab for neovascular age-related macular degeneration

American Journal of Health-System Pharmacy, 2008
The pharmacology, pharmacokinetics, clinical efficacy, safety, pharmacoeconomics, and place in therapy of ranibizumab are reviewed.Ranibizumab is the humanized fragment of the murine monoclonal antibody that binds all the active forms of the vascular endothelial growth factor, leading to the inhibition of the neovascular process underlying age-related ...
Luis Javier, Hernandez-Pastor, Ana, Ortega, Alfredo, Garcia-Layana, Joaquin, Giraldez   +3 more
openaire   +2 more sources

Hyperopia and Neovascularization in Age-related Macular Degeneration

Ophthalmology, 1993
Refractive errors for phakic eyes of patients referred with age-related macular degeneration were reviewed to determine whether some range of refractive error might be a risk factor for the neovascular form.The authors compared refractive errors of 198 patients with unilateral neovascular disease with refractive errors of 129 patients with bilateral ...
M A, Sandberg, M J, Tolentino, S, Miller, E L, Berson, A R, Gaudio   +4 more
openaire   +2 more sources

Management of neovascular age-related macular degeneration

Progress in Retinal and Eye Research, 2007
Neovascular age-related macular degeneration (AMD) is becoming an increasing socio-medical problem as the proportion of the aged population is continuously increasing. However, new insights in the pathogenesis of the disease offer the opportunity to develop targeted therapies that attack the disease process more successfully than ever.
Ursula M, Schmidt-Erfurth, Christian, Pruente   +1 more
openaire   +2 more sources

Neovascular Age-Related Macular Degeneration

Ophthalmology, 2013
Age-related macular degeneration (AMD) progresses through early and intermediate to advanced stages, one of which is neovascular AMD (nAMD). A correct diagnosis of nAMD at an early stage is critical because unlike geographic atrophy, it can be treated with therapeutic agents.
Bianca S. Gerendas, Julia S. Kroisamer, Florian Sulzbacher, Ursula Schmidt-Erfurth   +3 more
openaire   +2 more sources

Neovascular Age-Related Macular Degeneration

Drugs, 2008
Age-related macular degeneration (AMD) affects an estimated 14 million people worldwide, and is the leading cause of severe, irreversible vision loss in individuals over the age of 50 years in Western societies. Choroidal neovascularization (CNV), the hallmark of 'wet', 'exudative' or 'neovascular' AMD, is responsible for approximately 90% of cases of ...
Aimee V, Chappelow, Peter K, Kaiser
openaire   +2 more sources

Ranibizumab for Neovascular Age-Related Macular Degeneration

New England Journal of Medicine, 2006
Ranibizumab--a recombinant, humanized, monoclonal antibody Fab that neutralizes all active forms of vascular endothelial growth factor A--has been evaluated for the treatment of neovascular age-related macular degeneration.In this multicenter, 2-year, double-blind, sham-controlled study, we randomly assigned patients with age-related macular ...
Philip J, Rosenfeld, David M, Brown, Jeffrey S, Heier, David S, Boyer, Peter K, Kaiser, Carol Y, Chung, Robert Y, Kim   +6 more
openaire   +2 more sources

Anxiety in Patients with Neovascular Age-related Macular Degeneration

Ophthalmic Epidemiology, 2022
The main objective of the study is to investigate the prevalence of anxiety in patients with neovascular age-related macular degeneration (nAMD).A retrospective cross-sectional study of 3 304 nAMD patients and 16 515 age- and gender-matched controls. The proportions of patients with anxiety were compared between the groups using univariate analyses and
Orly, Weinstein, Arnon D, Cohen, Jaime, Levy, Ofira, Zloto, Tamar, Freud, Israel, Krieger, Doron, Comaneshter, Rachel, Shemesh   +7 more
openaire   +2 more sources